JPP’s patented technology is designed for all instruments that are in common use today, all of which incorporate a single heated reaction chamber.
Under Patent 2 and Patent 3, straightforward and inexpensive modifications to currently configured instruments remove all the difficulties associated with the Moore & Stein method, whilst providing superior sensitivity and improved analytical performance. A different modification is protected under each of Patents 2 & 3, with an ‘either/or’ option being offered.
A reagent formulation prepared under Patent 1 (which as a result of the chemistry involved produce slightly lower sensitivity when used on unmodified instruments) is already in use and has proved extremely effective in a commercial setting. Outstanding levels of sensitivity are achieved, however, when ‘Patent 1’ reagents are used on instruments modified under either of JPP’s Patents 2 or 3.
Single-bottle reagents formulated under Patent 1 might thus be regarded as ‘all purpose’. These reagents achieve slightly reduced – but still generally acceptable – levels of sensitivity when used on unmodified instruments in common use today, whilst under either Patent 2 or Patent 3, much greater analytical performance and sensitivity is guaranteed.
The Patent 1 ‘single bottle’ trademarked reagent is produced and supplied by a leading international supplier to the industry based in the UK. This reagent has been satisfactorily adopted by a significant number of leading UK and international medical and scientific establishments. Its use in a clinical setting has been approved by the appropriate regulatory bodies and it has been certified to have a life in the presence of air at room temperature of at least 3 years.